Exact Mass: 457.1671332000001
Exact Mass Matches: 457.1671332000001
Found 401 metabolites which its exact mass value is equals to given mass value 457.1671332000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Amygdaloside
C20H27NO11 (457.15840320000007)
Amygdalin is found in almond. Bitter glycoside of the Rosaceae, found especially in kernels of cherries, peaches and apricots. Amygdalin is present in cold pressed bitter almond oil from the above sources prior to enzymic hydolysis and steam distillation for food use Amygdalin , C20H27NO11, is a glycoside initially isolated from the seeds of the tree Prunus dulcis, also known as bitter almonds, by Pierre-Jean Robiquet and A. F. Boutron-Charlard in 1803, and subsequently investigated by Liebig and Wohler in 1830, and others. Several other related species in the genus of Prunus, including apricot (Prunus armeniaca) and black cherry (Prunus serotina), also contain amygdalin. It was promoted as a cancer cure by Ernst T. Krebs under the name "Vitamin B17", but studies have found it to be ineffective. Amygdalin is sometimes confounded with laevomandelonitrile, also called laetrile for short; however, amygdalin and laetrile are different chemical compounds (R)-amygdalin is an amygdalin in which the stereocentre on the cyanohydrin function has R-configuration. It has a role as a plant metabolite, an apoptosis inducer and an antineoplastic agent. It is functionally related to a (R)-mandelonitrile. D-Amygdalin is a natural product found in Prunus spinosa, Gerbera jamesonii, and other organisms with data available. Amygdalin is a cyanogenic glucoside isolated from almonds and seeds of other plants of the family Rosaceae. Amygdalin is converted by plant emulsin (a combination of a glucosidase and a nitrilase) or hydrochloric acid into benzaldehyde, D-glucose, and hydrocyanic acid. (NCI04) A cyanogenic glycoside found in the seeds of Rosaceae. Amygdalin is a bitter glycoside of the Rosaceae, found in sources such as kernels of cherries, peaches and apricots. Present in cold pressed bitter almond oil from the these sources prior to enzymic hydolysis and steam distillation for food use. Amygdalin can also be found in passion fruit. C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C29724 - Cyanoglycoside Agent D000970 - Antineoplastic Agents C1907 - Drug, Natural Product Amygdalin is a plant glucoside isolated from the stones of rosaceous fruits, such as apricots, peaches, almond, cherries, and plums. Amygdalin is a plant glucoside isolated from the stones of rosaceous fruits, such as apricots, peaches, almond, cherries, and plums.
Minocycline
C23H27N3O7 (457.18489120000004)
Minocycline is only found in individuals that have used or taken this drug. It is a tetracycline analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant staphylococcus infections. [PubChem]Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis. A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3205 KEIO_ID M159; [MS3] KO009052 KEIO_ID M159; [MS2] KO009051 KEIO_ID M159
5,10-Methylene-THF
5,10-Methylene-THF is an intermediate in glycine, serine and threonine metabolism and one carbon metabolism. 5,10-CH2-THF can also be used as a coenzyme in the biosynthesis of thymidine. More specifically it is the C1-donor in the reactions catalyzed by thymidylate synthase and thymidylate synthase (FAD). It also acts as a coenzyme in the synthesis of serine from glycine via the enzyme serine hydroxymethyl transferase. 5,10-Methylene-THF is a substrate for Methylenetetrahydrofolate reductase. This enzyme converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. This reaction is required for the multistep process that converts the amino acid homocysteine to methionine. The body uses methionine to make proteins and other important compounds. 5,10-CH2-THF is a substrate for many enzymes including Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), Aminomethyltransferase (mitochondrial), Serine hydroxymethyltransferase (mitochondrial), Methylenetetrahydrofolate reductase, C-1-tetrahydrofolate synthase (cytoplasmic), Serine hydroxymethyltransferase (cytosolic) and Thymidylate synthase. 5,10-Methylene-THF is an intermediate in the metabolism of Methane and the metabolism of Nitrogen. It is a substrate for Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase (mitochondrial), Aminomethyltransferase (mitochondrial), Serine hydroxymethyltransferase (mitochondrial), Methylenetetrahydrofolate reductase, C-1-tetrahydrofolate synthase (cytoplasmic), Serine hydroxymethyltransferase (cytosolic) and Thymidylate synthase. [HMDB] COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
O-Demethylpuromycin
C21H27N7O5 (457.20735720000005)
A derivative of puromycin lacking the O-methyl group on the tyrosyl residue.
AZIMILIDE
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
OA-6129 A
C20H31N3O7S (457.18826160000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
3-O-Acetylpapaveroxine
C24H27NO8 (457.17365820000003)
A benzylisoquinoline alkaloid that is 3-O-acetyl-4-O-demethylpapaveroxine in which the phenolic hydroxy group has been converted to the corresponding methyl ether. An intermediate in the biosynthesis of noscarpine in the opium poppy, Papaver somniferum.
Evotopin
C23H23N3O5.HCl (457.14044040000005)
Topotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I. See also: Topotecan (has active moiety). C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities. Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
Mandelonitrile sophoroside
C20H27NO11 (457.15840320000007)
Mandelonitrile sophoroside is isolated from leaves of perilla (Perilla frutescens var. acuta). Isolated from leaves of perilla (Perilla frutescens variety acuta)
5-Methyldihydrofolic acid
5-Methyldihydrofolic acid is a biopterin derivative present in human body fluids and tissues. (PMID: 932231) [HMDB] 5-Methyldihydrofolic acid is a biopterin derivative present in human body fluids and tissues. (PMID: 932231).
(6R)-5,10-Methylenetetrahydrofolate
Azimilide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(4S,4As,5aR,12aS)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
C23H27N3O7 (457.18489120000004)
Etrasimod
C26H26F3NO3 (457.18646820000004)
N-(4-(2,5-Dihydro-5-oxo-3-furanyl)phenyl)-4-(beta-D-glucopyranosyloxy)benzamide
Bisindolylmaleimide IX
2-[[4-[(2-Amino-1-methyl-4-oxo-2,3-dihydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
2-[[4-[(2-Amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-4-methylidenepentanedioic acid
Triazoledione
1-[[5-(4-Chlorophenyl)furan-2-yl]methylideneamino]-4-hydroxy-3-[4-(4-methylpiperazin-1-yl)butyl]imidazol-2-one
6-Oxocamphor
C23H24ClN3O5 (457.14044040000005)
6-oxocamphor, also known as topotecan or hycamtin, is a member of the class of compounds known as camptothecins. Camptothecins are heterocyclic compounds comprising a planar pentacyclic ring structure, that includes a pyrrolo[3,4-beta]-quinoline moiety (rings A, B and C), conjugated pyridone moiety (ring D) and one chiral center at position 20 within the alpha-hydroxy lactone ring with (S) configuration (the E-ring). 6-oxocamphor can be found in common sage, which makes 6-oxocamphor a potential biomarker for the consumption of this food product. C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities. Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(4-hydroxyphenyl)acetonitrile
C20H27NO11 (457.15840320000007)
(2,3-dihydro-1-oxo-1H-pyrrolo[1,2-a]pyrrol-7-yl)methyl (2S*,3S*)-3-[(beta-D-glucopyranosyl)oxy]-2-hydroxy-2-(1-methylethyl)butanoate
C21H31NO10 (457.19478660000004)
N-Ac-11-[(2-Amino-2-carboxyethyl)thio]-12-hydroxy-5,7,9-hexadecatrienedioic acid
1,4-Lactone,tri-N-benzoyl-(2S,3S,4R)-2,3,5-Triamino-4-hydroxypentanoic acid
C26H23N3O5 (457.16376280000003)
methyl (6aS,11R,12bS)-5,6,6a,7,9,10,11,12,12a,12b-decahydro-13-hydroxy-3-{2-[(methoxycarbonyl)oxy]ethyl}-10,12b-dimethyl-4-oxo-4H-11,1-(metheno)azuleno[4,5-a]indolizine-2-carboxylate|paxiphylline C
4-hydroxyphenylacetonitrile 4-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranoside|adenophoraside D
C20H27NO11 (457.15840320000007)
Amygdalin
C20H27NO11 (457.15840320000007)
D000970 - Antineoplastic Agents (R)-amygdalin is an amygdalin in which the stereocentre on the cyanohydrin function has R-configuration. It has a role as a plant metabolite, an apoptosis inducer and an antineoplastic agent. It is functionally related to a (R)-mandelonitrile. D-Amygdalin is a natural product found in Prunus spinosa, Gerbera jamesonii, and other organisms with data available. Amygdalin is a cyanogenic glucoside isolated from almonds and seeds of other plants of the family Rosaceae. Amygdalin is converted by plant emulsin (a combination of a glucosidase and a nitrilase) or hydrochloric acid into benzaldehyde, D-glucose, and hydrocyanic acid. (NCI04) A cyanogenic glycoside found in the seeds of Rosaceae. C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C29724 - Cyanoglycoside Agent An amygdalin in which the stereocentre on the cyanohydrin function has R-configuration. C1907 - Drug, Natural Product Origin: Plant; Formula(Parent): C20H27NO11; Bottle Name:Amygdalin; PRIME Parent Name:Amygdalin; PRIME in-house No.:V0293, Glycosides, Nitriles Annotation level-1 Neoamygdalin is a natural product found in Prunus virginiana, Prunus serotina, and other organisms with data available. Amygdalin is a cyanogenic glucoside isolated from almonds and seeds of other plants of the family Rosaceae. Amygdalin is converted by plant emulsin (a combination of a glucosidase and a nitrilase) or hydrochloric acid into benzaldehyde, D-glucose, and hydrocyanic acid. (NCI04) A cyanogenic glycoside found in the seeds of Rosaceae. Amygdalin is a plant glucoside isolated from the stones of rosaceous fruits, such as apricots, peaches, almond, cherries, and plums. Amygdalin is a plant glucoside isolated from the stones of rosaceous fruits, such as apricots, peaches, almond, cherries, and plums. Neoamygdalin is a compound identified in the different processed bitter almonds. Neoamygdalin has the potential for the research of cough and asthma[1].
ro 31-8220
phenyl(1,2,9,10-tetramethoxy-6-methyl-5,6-dihydro-4H-dibenzo[de,g]quinolin-7-yl)methanone
C28H27NO5 (457.18891320000006)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.432 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.437
Topotecan Hcl
C23H24ClN3O5 (457.14044040000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities. Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
C20H27NO11_{[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}(4-hydroxyphenyl)acetonitrile
C20H27NO11 (457.15840320000007)
C20H27NO11_(2S)-{[6-O-(beta-D-Glucopyranosyl)-beta-D-glucopyranosyl]oxy}(phenyl)acetonitrile
C20H27NO11 (457.15840320000007)
Minocycline
C23H27N3O7 (457.18489120000004)
A - Alimentary tract and metabolism > A01 - Stomatological preparations > A01A - Stomatological preparations > A01AB - Antiinfectives and antiseptics for local oral treatment D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AF - Antiinfectives for treatment of acne A tetracycline analogue having a dimethylamino group at position 7 and lacking the methyl and hydroxy groups at position 5. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Ingliforib
C23H24ClN3O5 (457.14044040000005)
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4226; ORIGINAL_PRECURSOR_SCAN_NO 4224 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4688; ORIGINAL_PRECURSOR_SCAN_NO 4686 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4213; ORIGINAL_PRECURSOR_SCAN_NO 4211 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4706; ORIGINAL_PRECURSOR_SCAN_NO 4704 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4782; ORIGINAL_PRECURSOR_SCAN_NO 4781 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4692; ORIGINAL_PRECURSOR_SCAN_NO 4691 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9076; ORIGINAL_PRECURSOR_SCAN_NO 9074 INTERNAL_ID 310; CONFIDENCE standard compound; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9076; ORIGINAL_PRECURSOR_SCAN_NO 9074 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9039; ORIGINAL_PRECURSOR_SCAN_NO 9036 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9056; ORIGINAL_PRECURSOR_SCAN_NO 9053 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9133; ORIGINAL_PRECURSOR_SCAN_NO 9130 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9091; ORIGINAL_PRECURSOR_SCAN_NO 9086 CONFIDENCE standard compound; INTERNAL_ID 310; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9148; ORIGINAL_PRECURSOR_SCAN_NO 9144
2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(4-hydroxyphenyl)acetonitrile_major
C20H27NO11 (457.15840320000007)
Ala Cys His Lys
C18H31N7O5S (457.21072760000004)
Ala Cys His Gln
Ala Cys Lys His
C18H31N7O5S (457.21072760000004)
Ala Cys Gln His
Ala His Cys Lys
C18H31N7O5S (457.21072760000004)
Ala His Cys Gln
Ala His Lys Cys
C18H31N7O5S (457.21072760000004)
Ala His Gln Cys
Ala Lys Cys His
C18H31N7O5S (457.21072760000004)
Ala Lys His Cys
C18H31N7O5S (457.21072760000004)
Ala Gln Cys His
Ala Gln His Cys
Cys Ala His Lys
C18H31N7O5S (457.21072760000004)
Cys Ala His Gln
Cys Ala Lys His
C18H31N7O5S (457.21072760000004)
Cys Ala Gln His
Cys His Ala Lys
C18H31N7O5S (457.21072760000004)
Cys His Ala Gln
Cys His Lys Ala
C18H31N7O5S (457.21072760000004)
Cys His Gln Ala
Cys Lys Ala His
C18H31N7O5S (457.21072760000004)
Cys Lys His Ala
C18H31N7O5S (457.21072760000004)
Cys Gln Ala His
Cys Gln His Ala
Gly His Met Asn
Gly His Asn Met
1,2,4-Triazolidine-3,5-dione, 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-4-(2-phenoxyethyl)-
Gly Met His Asn
Gly Met Asn His
Gly Asn His Met
Gly Asn Met His
His Ala Cys Lys
C18H31N7O5S (457.21072760000004)
His Ala Cys Gln
His Ala Lys Cys
C18H31N7O5S (457.21072760000004)
His Ala Gln Cys
His Cys Ala Lys
C18H31N7O5S (457.21072760000004)
His Cys Ala Gln
His Cys Lys Ala
C18H31N7O5S (457.21072760000004)
His Cys Gln Ala
His Gly Met Asn
His Gly Asn Met
His Lys Ala Cys
C18H31N7O5S (457.21072760000004)
His Lys Cys Ala
C18H31N7O5S (457.21072760000004)
His Met Gly Asn
His Met Asn Gly
His Asn Gly Met
His Asn Met Gly
His Asn Ser Thr
C17H27N7O8 (457.19210219999997)
His Asn Thr Ser
C17H27N7O8 (457.19210219999997)
His Gln Ala Cys
His Gln Cys Ala
His Gln Ser Ser
C17H27N7O8 (457.19210219999997)
His Ser Asn Thr
C17H27N7O8 (457.19210219999997)
His Ser Gln Ser
C17H27N7O8 (457.19210219999997)
His Ser Ser Gln
C17H27N7O8 (457.19210219999997)
His Ser Thr Asn
C17H27N7O8 (457.19210219999997)
His Thr Asn Ser
C17H27N7O8 (457.19210219999997)
His Thr Ser Asn
C17H27N7O8 (457.19210219999997)
Lys Ala Cys His
C18H31N7O5S (457.21072760000004)
Lys Ala His Cys
C18H31N7O5S (457.21072760000004)
Lys Cys Ala His
C18H31N7O5S (457.21072760000004)
Lys Cys His Ala
C18H31N7O5S (457.21072760000004)
Lys His Ala Cys
C18H31N7O5S (457.21072760000004)
Lys His Cys Ala
C18H31N7O5S (457.21072760000004)
Met Gly His Asn
Met Gly Asn His
Met His Gly Asn
Met His Asn Gly
Met Asn Gly His
Met Asn His Gly
Met Asn Pro Pro
C19H31N5O6S (457.19949460000004)
Met Pro Asn Pro
C19H31N5O6S (457.19949460000004)
Met Pro Pro Asn
C19H31N5O6S (457.19949460000004)
Asn Gly His Met
Asn Gly Met His
Asn His Gly Met
Asn His Met Gly
Asn His Ser Thr
C17H27N7O8 (457.19210219999997)
Asn His Thr Ser
C17H27N7O8 (457.19210219999997)
Asn Met Gly His
Asn Met His Gly
Asn Met Pro Pro
C19H31N5O6S (457.19949460000004)
Asn Asn Asn Pro
C17H27N7O8 (457.19210219999997)
Asn Asn Pro Asn
C17H27N7O8 (457.19210219999997)
Asn Pro Met Pro
C19H31N5O6S (457.19949460000004)
Asn Pro Asn Asn
C17H27N7O8 (457.19210219999997)
Asn Pro Pro Met
C19H31N5O6S (457.19949460000004)
Asn Ser His Thr
C17H27N7O8 (457.19210219999997)
Asn Ser Thr His
C17H27N7O8 (457.19210219999997)
Asn Thr His Ser
C17H27N7O8 (457.19210219999997)
Asn Thr Ser His
C17H27N7O8 (457.19210219999997)
Pro Met Asn Pro
C19H31N5O6S (457.19949460000004)
Pro Met Pro Asn
C19H31N5O6S (457.19949460000004)
Pro Asn Met Pro
C19H31N5O6S (457.19949460000004)
Pro Asn Asn Asn
C17H27N7O8 (457.19210219999997)
Pro Asn Pro Met
C19H31N5O6S (457.19949460000004)
Pro Pro Met Asn
C19H31N5O6S (457.19949460000004)
Pro Pro Asn Met
C19H31N5O6S (457.19949460000004)
Gln Ala Cys His
Gln Ala His Cys
Gln Cys Ala His
Gln Cys His Ala
Gln His Ala Cys
Gln His Cys Ala
Gln His Ser Ser
C17H27N7O8 (457.19210219999997)
Gln Ser His Ser
C17H27N7O8 (457.19210219999997)
Gln Ser Ser His
C17H27N7O8 (457.19210219999997)
Ser His Asn Thr
C17H27N7O8 (457.19210219999997)
Ser His Gln Ser
C17H27N7O8 (457.19210219999997)
Ser His Ser Gln
C17H27N7O8 (457.19210219999997)
Ser His Thr Asn
C17H27N7O8 (457.19210219999997)
Ser Asn His Thr
C17H27N7O8 (457.19210219999997)
Ser Asn Thr His
C17H27N7O8 (457.19210219999997)
Ser Gln His Ser
C17H27N7O8 (457.19210219999997)
Ser Gln Ser His
C17H27N7O8 (457.19210219999997)
Ser Ser His Gln
C17H27N7O8 (457.19210219999997)
Ser Ser Gln His
C17H27N7O8 (457.19210219999997)
Ser Thr His Asn
C17H27N7O8 (457.19210219999997)
Ser Thr Asn His
C17H27N7O8 (457.19210219999997)
Thr His Asn Ser
C17H27N7O8 (457.19210219999997)
Thr His Ser Asn
C17H27N7O8 (457.19210219999997)
Thr Asn His Ser
C17H27N7O8 (457.19210219999997)
Thr Asn Ser His
C17H27N7O8 (457.19210219999997)
Thr Ser His Asn
C17H27N7O8 (457.19210219999997)
Thr Ser Asn His
C17H27N7O8 (457.19210219999997)
5-Methyldihydrofolic acid
A member of the class of dihydrofolic acids that is dihydrofolic acid carrying a methyl substituent at position 5.
Trp-Met-OH
C22H23N3O6S (457.13074980000005)
Mandelonitrile sophoroside
C20H27NO11 (457.15840320000007)
{[2-O-(6-Deoxy-?-L-mannopyranosyl)-?-D-glucopyranosyl]oxy}(4-hydroxyphenyl)acetonitrile
C20H27NO11 (457.15840320000007)
16-carboxy-17,18,19,20-tetranor-N-acetyl-LTE3
azd-8186
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-6-methyl-N-(3-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-(2-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-(3-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
Benzenaminium,4-[[4-(dimethylamino)phenyl][4-(dimethyliminio)-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-N,N-dimethyl-,bromide chloride (1:1:1)
C26H33Cl2N3 (457.20513980000004)
[R-(E)]-alpha-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol
C29H28ClNO2 (457.18084580000004)
6-nitrooxyhexyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate
Fmoc-(S)-3-Amino-4-(3-benzothienyl)-butyric acid
C27H23NO4S (457.13477180000007)
Methyl-[E]-2-[3(S)-[3-[2-(7-chloro-2-quinolinyl)-ethenyl]-phenyl] -3-hydroxy propyl]-benzoate
C28H24ClNO3 (457.14446240000007)
Methyl 2-[(3S)-3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxypropyl]benzoate
C28H24ClNO3 (457.14446240000007)
2-amino-2-ethylpropane-1,3-diol,(4-nitrophenyl) dihydrogen phosphate
C16H32N3O10P (457.18252220000005)
[(S)-(E)]-2-[3-[3-[2-(7-chloro-2-quinolinyl)-ethenyl]-phenyl]-3-hydroxy propyl]-phenyl]-2-Propanol
C29H28ClNO2 (457.18084580000004)
[4-(2,4-difluorophenyl)-2-[(2,5-dimethylphenyl)carbamoyl]phenyl] benzoate
C28H21F2NO3 (457.14894200000003)
2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-7-methyl-N-(4-methylphenyl)- (9CI)
C27H27N3O2S (457.18238820000005)
BOC-THIONOSER(BZL)-1-(6-NITRO)BENZOTRIAZOLIDE
C21H23N5O5S (457.14198280000005)
Fmoc-(R)-3-Amino-4-(3-benzothienyl)-butyric acid
C27H23NO4S (457.13477180000007)
10-Phenyl-10H-spiro[acridine-9,9-fluorene]-2,7-dicarbonitrile
1H-Indol-3-yl 4-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
C20H27NO11 (457.15840320000007)
5-(5-Chloro-2,4-Dihydroxyphenyl)-N-Ethyl-4-[4-(Morpholin-4-Ylmethyl)phenyl]isoxazole-3-Carboxamide
C23H24ClN3O5 (457.14044040000005)
Bisindolylmaleimide IX
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D004791 - Enzyme Inhibitors
Tematropium metilsulfate
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
2-imino-8-methyl-5-oxo-1-(2-oxolanylmethyl)-N-(2-phenylethyl)-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxamide
(6R)-5,10-Methylenetetrahydrofolate
C2140 - Adjuvant > C2078 - Folic Acid Derivative
2-(2-{2-[(Biphenyl-4-ylmethyl)-amino]-3-mercapto-pentanoylamino}-acetylamino)-3-methyl-butyric acid methyl ester
C24H31N3O4S (457.20351660000006)
1,2-DI-N-Pentanoyl-SN-glycero-3-dithiophosphocholine
C18H36NO6PS2 (457.17215660000005)
1-(2-{[(6-Amino-2-Methylpyridin-3-Yl)methyl]amino}ethyl)-6-Chloro-3-[(2,2-Difluoro-2-Pyridin-2-Ylethyl)amino]-1,4-Dihydropyrazin-2-Ol
C20H30ClF2N7O (457.21683040000005)
3-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one
C26H23N3O5 (457.16376280000003)
D004791 - Enzyme Inhibitors
[(3R,4R,6R)-2,3-dihydroxy-2-methyl-6-(12-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)oxan-4-yl]azanium
2-amino-N-[(2R,3R,4S,5S)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanamide
C21H27N7O5 (457.20735720000005)
1-[[5-(4-Chlorophenyl)furan-2-yl]methylideneamino]-4-hydroxy-3-[4-(4-methylpiperazin-1-yl)butyl]imidazol-2-one
5,10-Methylenetetrahydrofolic acid
C2140 - Adjuvant > C2078 - Folic Acid Derivative
Syncarpamide
C28H27NO5 (457.18891320000006)
An alkaloid that is the di-O-cinnamoyl derivative of 3,4-di-O-methylnorepinephrine. Isolated from Zanthoxylum syncarpum, it exhibits antiplasmodial activity.
alisiaquninone C
C23H23NO7S (457.11951680000004)
An organic heterohexacyclic compound that is isolated from New Caledonian deep water sponge and exhibits antiplasmodial properties.
2-[4-(2,2-Dimethyl-4-oxo-1,3,5,6-tetrahydrobenzo[a]phenanthridin-5-yl)-2-methoxyphenoxy]acetic acid
C28H27NO5 (457.18891320000006)
(1S,4aS,11aR,12aS)-3-carbamoyl-10-(dimethylamino)-1-(dimethylazaniumyl)-4a,5,7-trihydroxy-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracen-2-olate
C23H27N3O7 (457.18489120000004)
6-(1-azepanylsulfonyl)-1-ethyl-N-(2-furanylmethyl)-4-oxo-3-quinolinecarboxamide
C23H27N3O5S (457.1671332000001)
1-[3-[1-Cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester
N-(2-ethoxyphenyl)-1-[4-(1-pyrrolidinylsulfonyl)phenyl]-4-piperidinecarboxamide
C24H31N3O4S (457.20351660000006)
ethyl 4-[[2-[4-(2-chlorophenyl)-2-oxo-6,7-dihydro-5H-cyclopenta[b]pyridin-1-yl]acetyl]amino]piperidine-1-carboxylate
C24H28ClN3O4 (457.1768238000001)
ethyl 4-(1,3-benzodioxol-5-yl)-6-[[2-(4-chlorophenyl)ethylamino]methyl]-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate
C23H24ClN3O5 (457.14044040000005)
4-Morpholinecarboxylic acid [4-[6-amino-5-cyano-3-(4-methylphenyl)-2,4-dihydropyrano[2,3-c]pyrazol-4-yl]phenyl] ester
C25H23N5O4 (457.17499580000003)
3-(4-ethylphenyl)-4-hydroxy-4-(4-pyridin-2-ylpiperazine-1-carbonyl)-1H-quinazolin-2-one
2,5-Dimethyl-4-[[2-oxo-2-(4-phenylbutan-2-ylamino)ethyl]thio]-6-thieno[2,3-d]pyrimidinecarboxylic acid ethyl ester
C23H27N3O3S2 (457.14937520000007)
4-[[[4-[(4-Fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazin-6-yl]-oxomethyl]amino]-1-piperidinecarboxylic acid ethyl ester
2,4-dihydroxy-3-({3-[(1S,4aS,5R,6R,7S,9S,9aR)-5-hydroxy-1,6-dimethyl-2-oxo-1,2,5,6,7,8,9,9a-octahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)benzoic acid
C24H27NO8 (457.17365820000003)
(4R,12aR)-4,7-bis(dimethylamino)-10,12a-dihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
C23H27N3O7 (457.18489120000004)
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
2-[(1S,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
2-[(1R,3R,4aR,9aS)-6-[(2-fluorophenyl)carbamoylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1S,3S,4aS,9aR)-6-[(2-fluorophenyl)carbamoylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1R,3S,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(pyridine-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
1-(2,5-difluorophenyl)-3-[(2R,3R,6R)-6-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]urea
2-[(1S,3S,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1S,3R,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1R,3S,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H27N3O4 (457.20014620000006)
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H27N3O4 (457.20014620000006)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H27N3O4 (457.20014620000006)
4-[[(6S,7S,8S)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-4-yl]methyl]benzoic acid methyl ester
C27H27N3O4 (457.20014620000006)
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(methoxymethyl)-1-triazolyl]ethyl]-3-oxanyl]-3-[4-(trifluoromethyl)phenyl]urea
C20H26F3N5O4 (457.1936792000001)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-4-methylbenzenesulfonamide
C22H27N5O4S (457.1783662000001)
2-[(1R,3R,4aS,9aR)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1S,3R,4aR,9aS)-6-[[(2-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1R,3R,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1S,3S,4aS,9aR)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1S,3S,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(1S,3R,4aR,9aS)-6-[[(4-fluoroanilino)-oxomethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-propylacetamide
C24H28FN3O5 (457.20128900000003)
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[oxo(pyridin-4-yl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3-fluorophenyl)methyl]acetamide
C24H28FN3O5 (457.20128900000003)
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H27N3O4 (457.20014620000006)
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H27N3O4 (457.20014620000006)
4-[[(6S,7R,8S)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-4-yl]methyl]benzoic acid methyl ester
C27H27N3O4 (457.20014620000006)
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-(4-methoxyphenyl)phenyl]-4-[1-oxo-2-(2-pyridinyl)ethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C27H27N3O4 (457.20014620000006)
4-[[(6R,7R,8S)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-4-yl]methyl]benzoic acid methyl ester
C27H27N3O4 (457.20014620000006)
4-[[(6R,7S,8R)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-4-yl]methyl]benzoic acid methyl ester
C27H27N3O4 (457.20014620000006)
4-[[(6R,7R,8R)-8-(hydroxymethyl)-2-oxo-7-[4-(3-pyridinyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-4-yl]methyl]benzoic acid methyl ester
C27H27N3O4 (457.20014620000006)
8-(6-aminohexylamino)-2-O-methyl 3,5-cyclic AMP
C17H28N7O6P (457.18385980000005)
4-(4-Butoxy-2-methylbenzoyl)-5-pyridin-4-yl-1-(pyridin-3-ylmethyl)pyrrolidine-2,3-dione
C27H27N3O4 (457.20014620000006)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2,3-dihydroxy-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
(2S,3S,4S,5R)-3,4,5-trihydroxy-6-[(5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaen-17-yl)oxy]oxane-2-carboxylic acid
C23H27N3O7 (457.18489120000004)
Antibiotic OA 6129A
C20H31N3O7S (457.18826160000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D013845 - Thienamycins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
minocycline zwitterion
C23H27N3O7 (457.18489120000004)
A zwitterion obtained by transfer of a proton from the 2-hydroxy group to the 1-amino group of minocycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
(6R)-5,10-Methylenetetrahydrofolic acid
The (6R)-stereoisomer of 5,10-methylenetetrahydrofolic acid.
platensimycin A1
C24H27NO8 (457.17365820000003)
A polycyclic cage that is the 5-hydroxy derivative of platensimycin. It is isolated from Streptomyces platensis.
5-Methyltetrahydrofolate(2-)
A dicarboxylic acid dianion resulting from the deprotonation of the two carboxy groups of 5-methyltetrahydrofolic acid; major species at pH 7.3.
Foliglurax (monohydrochloride)
C23H24ClN3O3S (457.12268240000003)
Foliglurax monohydrochloride (PXT002331 monohydrochloride) is a highly selective and potent, brain-penetrant metabotropic glutamate receptor 4 positive allosteric modulator (mGluR4 PAM) , with an EC50 of 79 nM[1]. Antiparkinsonian effect[1].
(2r,3r,4s,5r,6r)-2-{12-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaen-3-yl}-6-methyloxane-3,4,5-triol
C26H23N3O5 (457.16376280000003)
(1s,2r,14r,15s)-4-methoxy-16,16,25-trimethyl-8,12,17-trioxa-25-azaheptacyclo[13.12.0.0²,¹⁴.0³,¹¹.0⁵,⁹.0¹⁸,²⁷.0¹⁹,²⁴]heptacosa-3(11),4,6,9,18(27),19,21,23-octaene-13,26-dione
ethyl 4-[(1-{10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene}ethyl)amino]butanoate
C24H27NO8 (457.17365820000003)
(2s)-2-[(4-{1-hydroxy-3-imino-4h,5h,6h,6ah,7h,9h-imidazo[1,5-f]pteridin-8-yl}phenyl)formamido]pentanedioic acid
(4s,4as,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
C23H27N3O7 (457.18489120000004)
(2s,3s,4r,5r)-3-{[(2s)-2-amino-1-hydroxy-3-(4-methoxyphenyl)propylidene]amino}-5-(6-aminopurin-9-yl)-4-hydroxyoxolane-2-carboxylic acid
(5as,6s,7ar,8r,9s,11as,11bs,12r)-6,9,12-trihydroxy-8-(hydroxymethyl)-5a,8,11a-trimethyl-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-1-one
n-[2,6-dihydroxy-3-(sulfanylcarbonyl)phenyl]-3-[(1s,5s,6r,7s,9s,10s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propanimidic acid
C24H27NO6S (457.1559002000001)
5-[(2r,4s,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-4-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione
C24H27NO8 (457.17365820000003)
(2r)-2-phenyl-2-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile
C20H27NO11 (457.15840320000007)
(2s)-2-amino-3-methyl-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}butanoic acid
(4s,12as)-4,7-bis(dimethylamino)-3,10,11,12a-tetrahydroxy-1,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
C23H27N3O7 (457.18489120000004)
(3s,4r,5s,7r,8r,9r,10s)-10-(3,5-dihydroxyphenyl)-4-hydroxy-8-[(2-hydroxyphenyl)amino]-3,5,7,9-tetramethyloxecane-2,6-dione
(2s)-2-({4-[(6ar)-1-hydroxy-3-imino-4h,5h,6h,6ah,7h,9h-imidazo[1,5-f]pteridin-8-yl]phenyl}formamido)pentanedioic acid
2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,7s,9s,11r)-11-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
n-{1,7-dichloro-2,5-dihydroxy-8-oxobicyclo[3.3.1]non-6-en-3-yl}-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
2-amino-3-methyl-3-[(3,4,5-trihydroxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)methoxy]butanoic acid
2-{12-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaen-3-yl}-6-methyloxane-3,4,5-triol
C26H23N3O5 (457.16376280000003)
2,4-dihydroxy-3-[(1-hydroxy-3-{12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,7s,9s)-9-(hydroxymethyl)-5-methyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
ethyl 4-({1-[(2r,4e)-10-acetyl-11,13-dihydroxy-2,12-dimethyl-3,5-dioxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(13),6,9,11-tetraen-4-ylidene]ethyl}amino)butanoate
C24H27NO8 (457.17365820000003)
(2s)-2-amino-n-[(2s,3s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanimidic acid
C21H27N7O5 (457.20735720000005)
5-[4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-4-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3(8),4,6-tetraene-2,9,13-trione
C24H27NO8 (457.17365820000003)
(7-oxo-5,6-dihydropyrrolizin-1-yl)methyl (2s,3s)-2-hydroxy-2-isopropyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate
C21H31NO10 (457.19478660000004)
(2s)-2-phenyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile
C20H27NO11 (457.15840320000007)
(1s,2r,14r,15r)-4-methoxy-22,26,26-trimethyl-8,12,27-trioxa-22-azaheptacyclo[13.8.4.0¹,¹⁵.0²,¹⁴.0³,¹¹.0⁵,⁹.0¹⁶,²¹]heptacosa-3(11),4,6,9,16,18,20,24-octaene-13,23-dione
6-[(acetyloxy)methyl]-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-5-yl 4-nitrobenzoate
C24H27NO8 (457.17365820000003)
methyl (1r,2s,6s,15s,16r)-18-hydroxy-11-{2-[(methoxycarbonyl)oxy]ethyl}-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,6r,7s,9r,12r)-12-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
n-[2-(3,4-dimethoxyphenyl)-2-[(3-phenylprop-2-enoyl)oxy]ethyl]-3-phenylprop-2-enimidic acid
C28H27NO5 (457.18891320000006)
(2e,4e,6r)-n-[(1r,2s,3s,5r)-1,7-dichloro-2,5-dihydroxy-8-oxobicyclo[3.3.1]non-6-en-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
(2r)-2-{[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-2-phenylacetonitrile
C20H27NO11 (457.15840320000007)
2,4-dihydroxy-3-({1-hydroxy-3-[9-(hydroxymethyl)-5-methyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
methyl 3,4-bis(4-hydroxyphenyl)-1-[2-(4-methoxyphenyl)-2-oxoethyl]pyrrole-2-carboxylate
5-chloro-2-(2-hydroxyethyl)-6a-methyl-9-(2-methylbut-2-enoyl)-3-(3-methylpent-1-en-1-yl)furo[2,3-h]isoquinoline-6,8-dione
C25H28ClNO5 (457.1655908000001)
methyl 18-hydroxy-11-{2-[(methoxycarbonyl)oxy]ethyl}-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate
(6as)-5-chloro-2-(2-hydroxyethyl)-6a-methyl-9-(2-methylbut-2-enoyl)-3-[(3s)-3-methylpent-1-en-1-yl]furo[2,3-h]isoquinoline-6,8-dione
C25H28ClNO5 (457.1655908000001)
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(1h-indol-3-yloxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
C20H27NO11 (457.15840320000007)
(5r,5ar,6s,9ar,9br)-6-[(acetyloxy)methyl]-6,9a-dimethyl-3-oxo-1h,5h,5ah,7h,8h,9h,9bh-naphtho[1,2-c]furan-5-yl 4-nitrobenzoate
C24H27NO8 (457.17365820000003)
(15r)-15-benzyl-3,11-dihydroxy-13-methyl-16-oxa-2,10,13-triazatricyclo[16.4.0.0⁴,⁹]docosa-1(22),2,4,6,8,10,18,20-octaene-14,17-dione
C26H23N3O5 (457.16376280000003)
(2r)-2-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2r,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxy}oxan-3-yl]oxy}-2-phenylacetonitrile
C20H27NO11 (457.15840320000007)
2-(hydroxymethyl)-6-{[3,4,5-trihydroxy-6-(1h-indol-3-yloxy)oxan-2-yl]methoxy}oxane-3,4,5-triol
C20H27NO11 (457.15840320000007)
(2e)-n-[(2r)-2-(3,4-dimethoxyphenyl)-2-{[(2e)-3-phenylprop-2-enoyl]oxy}ethyl]-3-phenylprop-2-enimidic acid
C28H27NO5 (457.18891320000006)
[(2r,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
n-(6,8-dichloro-4a-hydroxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-3-yl)-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
(7-oxo-5,6-dihydropyrrolizin-1-yl)methyl 2-hydroxy-2-isopropyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate
C21H31NO10 (457.19478660000004)
(2r,3r,4r,5s,6s)-2-{12-hydroxy-3,13,23-triazahexacyclo[14.7.0.0²,¹⁰.0⁴,⁹.0¹¹,¹⁵.0¹⁷,²²]tricosa-1(16),2(10),4(9),5,7,11(15),12,17(22),18,20-decaen-3-yl}-6-methyloxane-3,4,5-triol
C26H23N3O5 (457.16376280000003)
(3r,4r,5s,7r,8r,9r,10s)-10-(3,5-dihydroxyphenyl)-4-hydroxy-8-[(2-hydroxyphenyl)amino]-3,5,7,9-tetramethyloxecane-2,6-dione
(2r)-2-phenyl-2-{[(4s,5s)-3,4,5-trihydroxy-6-({[(3r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile
C20H27NO11 (457.15840320000007)
{6-[cyano(phenyl)methoxy]-3,4,5-trihydroxyoxan-2-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(11r,15r,17r)-5-[(4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-6-hydroxy-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-[(1-hydroxy-3-{10-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO8 (457.17365820000003)
2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,7s,9s,10r)-10-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]propylidene}amino)benzoic acid
C24H27NO8 (457.17365820000003)
2-amino-n-[(2s,3s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanimidic acid
C21H27N7O5 (457.20735720000005)
3-[(4as,6ar,10ar,10bs)-3-carboxy-4a,7,7,10a-tetramethyl-1h,5h,6h,6ah,8h,9h,10h,10bh-cyclohexa[f]chromen-2-yl]pyridine-2,6-dicarboxylic acid
2-{[4,5-dihydroxy-2-(hydroxymethyl)-6-[(3,4,5,6-tetrahydroxyoxan-2-yl)methoxy]oxan-3-yl]oxy}-2-phenylacetonitrile
C20H27NO11 (457.15840320000007)
(2e)-n-[(2s)-2-(3,4-dimethoxyphenyl)-2-{[(2e)-3-phenylprop-2-enoyl]oxy}ethyl]-3-phenylprop-2-enimidic acid
C28H27NO5 (457.18891320000006)
(2e,4e,6r)-n-[(3s,4as,8r,8ar)-6,8-dichloro-4a-hydroxy-7-oxo-3,4,8,8a-tetrahydro-2h-1-benzopyran-3-yl]-4,6-dimethyldodeca-2,4-dienimidic acid
C23H33Cl2NO4 (457.17865180000007)
2,4-dihydroxy-3-[(1-hydroxy-3-{11-hydroxy-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}propylidene)amino]benzoic acid
C24H27NO8 (457.17365820000003)
15-benzyl-3,11-dihydroxy-13-methyl-16-oxa-2,10,13-triazatricyclo[16.4.0.0⁴,⁹]docosa-1(22),2,4,6,8,10,18,20-octaene-14,17-dione
C26H23N3O5 (457.16376280000003)